Title : Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia.

Pub. Date : 2017 Jul

PMID : 28418085






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In in vivo AML xenografts, puquitinib alone showed stronger efficacy than the well-known p110delta inhibitor, CAL-101, in association with a reduction in AKT and ERK phosphorylation in tumor tissues, without causing noticeable toxicity. idelalisib mitogen-activated protein kinase 1 Homo sapiens